Cognitive Change Clinical Trial
— COVID-19Official title:
Effect of Probiotic Strain Lactobacillus Paracasei PS23 on Brain Fog in People With Long COVID
The goal of this clinical trial is to test whether the intervention of probiotics supplement can improve symptoms of long covid syndrome. Participants will be given probiotics or placebo capsules for two month. Symptom questionnaires, cognitive function, eeg and fecal sample are recorded/collected before and after the supplement. Researchers will compare the probiotic group and the placebo to see if probiotic supplement really make differences.
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | December 2025 |
Est. primary completion date | August 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 80 Years |
Eligibility | Inclusion Criteria: - 20 to 80 year old - had been infected by SARS-CoV-2 - Stable vital signs - Have brain fog conplaint - MoCA<30 at baseline Exclusion Criteria: - refuse to join the study or refuse to sign the Informed Consent Form - have other neurological disease that may affect cognitive function, such as Parkinson disease, Seizure, etc. - have other gastrointestinal disease that may affect cognitive function, including tumors. - severe hearing loss or visual loss that may hinder cognitive function tests - Taken anti-seizure drug in 7 days. - Already taking probiotics supplement regularly - Taken antibiotics in two weeks - taking stool softener or laxative regularly - have valvular heart disease - have congenital or acquired immunodeficiency or is under iimmunosuppressant therapy - Pregnant or plans to be pregnant - BMI>30 - Have been performed severe gastrointestinal surgery(s) - Severe liver, kidney, cardiovascular, hematologic or metabolic disorder - In critical condition |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Taipei Veterans General Hospital, Taiwan |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Long covid related symptoms | A list of symptoms related to long covid including cough, fatigue. brain fog etc. | baseline and two months after probiotic/placebo supplement | |
Primary | Hospital Anxiety and Depression Scale | A measurement of the degree of depression and anxiety, with 7 questions each and 0-3 points for each question. Two scores ranging from 0-21 will be calculated, with higher points meaning more severe depression or anxiety. | baseline and two months after probiotic/placebo supplement | |
Primary | The Pittsburgh sleep quality index | A measurement of the degree of sleep disturbance/disorder. The score ranges from 0-21, with higher points meaning more severe sleep problem. | baseline and two months after probiotic/placebo supplement | |
Primary | Fatigue Severity Scale | A measurement of the degree of fatigue, with score ranging from 7-49 and higher points meaning more severe fatigue. | baseline and two months after probiotic/placebo supplement | |
Primary | GI symptoms | Rome Criteria Questionnaire in functional UGI disease and Rome Criteria Questionnaire in IBS are included in the questionnaire are measured to see if probiotic/placebo supplement results in adverse gi events or a change of bowel habits. | baseline and two months after probiotic/placebo supplement | |
Primary | Cognitive function-Digit symbol substitution test | a list of paired numbers and symbols are given to participants, and they are ask to match symbols to numbers accordingly. The number of question they answer within 90 second will be recorded. | baseline and two months after probiotic/placebo supplement | |
Primary | Cognitive function-The Montreal Cognitive Assessment(MoCA) | Score ranging from 0-30, with higher meaning better cognitive function | baseline and two months after probiotic/placebo supplement | |
Primary | Cognitive function-Color Trails making Test | The test is composed of two parts, easy and hard. The time taken to finish the two parts are recorded | baseline and two months after probiotic/placebo supplement | |
Primary | Cognitive function-Cogstate Brief Battery (CBB) | A cognitive test on ipad. | baseline and two months after probiotic/placebo supplement | |
Primary | EEG | 2 minutes of resting-state eye-open eeg were recored. After a brief rest, a working memory task will be repeated for 12 times.
In the task, subjects will be shown balls in a 5*5 chart, the location of which They are asked to remember. 6 second later, they are shown another ball, and they will be asked if the location of the newly shown ball are identical with any of the originally shown balls. |
baseline and two months after probiotic/placebo supplement | |
Primary | Gut microbiota | Subjects will be asked to collect their fecal sample and the bacterial DNA/RNA will be extracted and analyzed. | baseline and two months after probiotic/placebo supplement | |
Primary | Fecal metabolite | Subjects will be asked to collect their fecal sample and the SCFAs in the sample will be measured. | baseline and two months after probiotic/placebo supplement |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05712005 -
Cognitive Testing in Diverse Populations to Further the Objective and Clinical Understanding of Cognivue Study
|
||
Completed |
NCT05343208 -
Effectiveness of Online Therapy to Prevent Burnout
|
N/A | |
Active, not recruiting |
NCT05143294 -
Conectar Jugando: Board Games in Elementary Classrooms (6-12 Years Old) to Improve Executive Functions
|
N/A | |
Completed |
NCT05267730 -
Conectar Jugando: Board Games in Rural Elementary Classrooms (6-12 Years Old) to Improve Executive Functions
|
N/A | |
Completed |
NCT03987477 -
Online Intervention to Modify Interpretation Biases in Depression
|
N/A | |
Completed |
NCT03695003 -
Cognitive Effects of Sage in Healthy Humans
|
N/A | |
Completed |
NCT05075850 -
Multicenter Sub-study for LAANTERN Registry NCT02392078 That Will Include Comprehensive Neuropsychological Assessment Data Collection
|
||
Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
Completed |
NCT03689348 -
Acute and Chronic Effects of Avena Sativa on Cognition and Stress
|
N/A | |
Completed |
NCT03674281 -
The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery System
|
N/A | |
Active, not recruiting |
NCT05229705 -
Exercise in Older Adults at Risk for Type 2 Diabetes
|
N/A | |
Suspended |
NCT05001789 -
Cognitive Functioning in Opioid Use Disorder
|
N/A | |
Terminated |
NCT03337282 -
Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
|
||
Recruiting |
NCT05014399 -
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
|
||
Completed |
NCT03657537 -
Effects of Ketone Bodies on Cognition in Type 2 Diabetes
|
Phase 1 | |
Completed |
NCT05543811 -
The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology
|
N/A | |
Recruiting |
NCT05699226 -
Amplitude Titration to Improve ECT Clinical Outcomes
|
N/A | |
Recruiting |
NCT05026541 -
Resilience to Sleep Deprivation and Changes in Sleep Architecture in Shoonya Meditators
|
N/A | |
Active, not recruiting |
NCT03255499 -
Efficacy of the MovinCog Intervention in Children
|
N/A | |
Not yet recruiting |
NCT06252376 -
Effects of Blood Pressure on Cognition and Cerebral Hemodynamics in PD
|
N/A |